INMB

INmune Bio Inc. is a clinical-stage immunology company developing treatments for cancer and neurodegenerative diseases. The company's approach focuses on reprogramming the patient's innate immune system to treat disease. INmune Bio's pipeline includes therapies targeting treatment-resistant cancers and Alzheimer's disease, with lead programs in clinical trials. The company's proprietary technology platform aims to enhance the immune system's ability to recognize and destroy diseased cells while preserving healthy tissue.